Bottom line
How much do FBT and PBE overlap?
43% of their top holdings overlap by weight. 14 securities appear in both funds' top 25, making up 45.8% of FBT's assets and 49.3% of PBE's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings FBT and PBE have in common
| Holding | % of FBT | % of PBE | Overlap |
|---|---|---|---|
| Veracyte Inc VCYT | 5.10% | 2.60% | 2.60% |
| Illumina Inc ILMN | 3.92% | 3.51% | 3.51% |
| Neurocrine Biosciences Inc NBIX | 3.53% | 2.66% | 2.66% |
| Bio-techne Corp TECH | 3.43% | 3.73% | 3.43% |
| Biogen Inc BIIB | 3.37% | 4.79% | 3.37% |
| Exelixis Inc EXEL | 3.32% | 2.64% | 2.64% |
| Incyte Corp INCY | 3.18% | 3.06% | 3.06% |
| Halozyme Therapeutics Inc HALO | 3.11% | 2.98% | 2.98% |
| Vertex Pharmaceuticals Inc VRTX | 3.07% | 4.99% | 3.07% |
| Repligen Corp RGEN | 3.07% | 3.04% | 3.04% |
| Biomarin Pharmaceutical Inc BMRN | 2.83% | 2.82% | 2.82% |
| Amgen Inc AMGN | 2.78% | 5.22% | 2.78% |
| United Therapeutics Corp UTHR | 2.56% | 4.08% | 2.56% |
| Alnylam Pharmaceuticals Inc ALNY | 2.52% | 3.17% | 2.52% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FBT
- Corcept Therapeutics Inc — 5.60%
- Neogenomics Inc — 5.12%
- Bruker Corp — 4.32%
- Alkermes Plc — 4.24%
- Krystal Biotech Inc — 3.87%
- Natera Inc — 3.79%
- Axsome Therapeutics Inc — 3.71%
- Arrowhead Pharmaceuticals Inc — 3.38%
- Argenx Se — 3.13%
- Biontech Se — 2.63%
- Genmab A/s — 2.62%
Only in PBE
- Invesco Private Prime Fund — 12.89%
- Regeneron Pharmaceuticals, Inc. — 5.47%
- CareDx, Inc. — 5.04%
- Invesco Private Government Fund — 4.97%
- Royalty Pharma PLC — 4.94%
- Gilead Sciences, Inc. — 4.43%
- Protagonist Therapeutics, Inc. — 3.40%
- Vericel Corp. — 3.27%
- Acadia Pharmaceuticals Inc. — 3.02%
- Qiagen N.V. — 2.89%
- BioCryst Pharmaceuticals, Inc. — 2.63%
Asset mix
| Asset type | FBT | PBE |
|---|---|---|
| Stocks | 100.0% | 100.1% |
| Cash & short-term funds | 0.1% | 17.9% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Country mix
| Country | FBT | PBE |
|---|---|---|
| US | 85.0% | 108.6% |
| GB | — | 4.9% |
| IE | 4.2% | — |
| NL | 3.1% | 2.9% |
| DE | 2.6% | — |
| DK | 2.6% | — |
| CH | 2.5% | — |
| KY | — | 1.6% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do FBT and PBE overlap?
What stocks do FBT and PBE have in common?
Should I own both FBT and PBE?
Which holds more stocks, FBT or PBE?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.